← Open Payments lookup

MARIA TAPIA: Open Payments

NPI 1962874214 · NEW BRITAIN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,030 in 87 payments from 11 companies in 2025. Trend: 2023 $1,820 · 2024 $2,145 · 2025 $2,030

Food & beverage: $1,906Education: $123
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.14$525
ABBVIE INC.39$502
Vanda Pharmaceuticals Inc.5$229
Supernus Pharmaceuticals, Inc.6$180
Otsuka America Pharmaceutical, Inc.13$172
Axsome Therapeutics, Inc.2$143
Janssen Pharmaceuticals, Inc1$125
Indivior Inc.4$89
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$24
E.R. Squibb & Sons, L.L.C.1$21

Products named: VRAYLAR, AUSTEDO XR, FANAPT, Qelbree, Auvelity, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII.

Industry payments across CT — which companies pay providers there.